RCM
ACHV icon

RA Capital Management’s Achieve Life Sciences ACHV Stock Holding History

RA Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-347
Closed -$7.08M – 32
2013
Q3 		$7.08M Sell
347
-45
-11% -$932K 0.74% 30
2013
Q2 		$8.46M Buy
+392
New +$8.77M 1.12% 19

Other funds holding ACHV

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RA Capital Management's ACHV Position: Q4 2013 in Review

RA Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2013, closing a stake of 347 shares — an estimated $7.08M sold.

RA Capital Management first reported a position in ACHV in Q2 2013 and held it in 2 quarters. The position peaked at $8.46M in Q2 2013. 61 funds tracked by Wall St. Rank hold ACHV as of Q4 2013.

  • RA Capital Management reported no remaining Achieve Life Sciences position as of Q4 2013 after selling out during the quarter.
  • RA Capital Management sold 347 Achieve Life Sciences shares in Q4 2013, an estimated $7.08M.
  • RA Capital Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 2 quarters.
  • RA Capital Management's Achieve Life Sciences position peaked at $8.46M in Q2 2013.
  • 61 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2013.

Based on RA Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.